Join our Pi3 kinase mutated tumor clinical trial
Take control of your fight with Faeth. Our science-backed precision nutrition program is designed to starve your cancer of the nutrients it needs to survive and grow. Our preclinical animal studies have shown that our program may also increase the effectiveness of standard treatments.
Contact us today to find out if you are eligible to join our clinical trial.
FTH 001 - A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Adult Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss
Memorial Sloan Kettering, New York NY
Mayo Clinic, Rochester MN
University of Texas Southwestern, Dallas TX
Pacific Cancer Specialists, Anaheim CA
Hoag, Orange County CA
University of Alabama, Birmingham AL
Medical College of Wisconsin, Milwaukee WI
East Carolina University, Greenville NC
University of Chicago, Chicago IL
University of Pennsylvania, Philadelphia PA
You may still be able to participate in a study if you are not being treated at one of these sites. To find out if you may still be eligible, please reach out to our clinical trial partner, Anova Evidence at (224)-218-2408 or firstname.lastname@example.org.